An API Innovation Center report highlighted four priorities to stabilize the U.S.-based supply of active pharmaceutical ingredients.
The report draws from roundtable discussions hosted at the nonprofit corporation in August, according to an Oct. 6 company news release. Leaders representing pharmaceutical manufacturing, hospital systems, retail pharmacies, government and the economic sector discussed what each needed to support a more reliable domestic supply chain. Currently, more than 250 medications are in shortage nationwide.
Here are the four priorities:
- Predictable demand and long-term contracts to de-risk private investment in U.S. manufacturing.
- A shift from lowest-cost purchasing to value-based models that reward reliability and quality.
- Greater transparency across the supply chain to enable smarter decisions and risk management.
- Broad stakeholder engagement to align incentives and ensure reliable access to critical medicines.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.